Forte Biosciences: MPM BioImpact reports 0% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Forte Biosciences, Inc. (FBRX) reports that MPM BioImpact LLC beneficially owned 0 shares of its common stock, or 0%, as of September 30, 2026. MPM BioImpact reported no sole or shared voting or dispositive power over the shares. The amendment identifies MPM BioImpact as an investment adviser and states ownership of 5% or less of the class.
Key Figures
Key Terms
beneficially owned technical
Sole Voting Power technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.